Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editorial Board

    Monther Al-Alwan
    Stem Cell and Tissue Re-engineering Program
    King Faisal Specialist Hospital and Research Centre
    Saudi Arabia
    MAlwan@kfshrc.edu.sa
    SSCRT

    Dr. Monther AlAlwan is a scientist at the Stem Cell and Tissue Re-engineering Program (SCTRP), King Faisal Specialist Hospital and Research Centre, as well as an Associate professor at Alfaisal University, Riyadh Saudi Arabia. He holds M.Sc. and Ph.D. in Immunology from Dalhousie University (Halifax, Canada). Dr. AlAlwan conducted a 3-years postdoctoral fellowship studying signaling in immune cells at the University of Manitoba, Canada. During his graduate studies and postdoctoral fellowship, Dr. AlAlwan made substantial contribution in the immunology field, particularly his groundbreaking discovery that highlighted the significance of the dendritic cells in the immunological synapse. After joining the SCTRP in 2007, he shifted gear to study cancer, where he identified novel mechanisms that regulate cancer metastasis and chemoresistance. Currently, he is actively involved in dissecting the molecular pathways that regulate the function of cancer stem cells and how this related to chemoresistance and metastasis. Dr. AlAlwan is an author in 20 peer-reviewed publications, has delivered several invited lectures and is a regular reviewer for various international journals.   

    More Info.
    Xiangxin Lou
    College of Chemistry, Chemical Engineering and Biotechnology
    Donghua University
    China
    xiangxin@dhu.edu.cn
    SSCRT

    Research Interest: Cell Reprogramming and Induced Pluripotent Stem Cells, Stem Cells and Neural Tissue Engineering, Mammalian Inner Ear Development and Hair Cell Regeneration.

    More Info.
    Manoj Gupta
    Research Fellow
    Joslin Diabetes Center
    USA
    manoj.gupta@joslin.harvard.edu
    SSCRT

    Research Interest: Leptin Receptors (Lepr) are Expressed by Various Types of Stem Cells Including Mesenchymal Stem Cells, Hematopoietic Stem Cells, Embryonic Stem Cells and Induced Pluripotent Stem Cells. Leptin/Lepr Signaling is also a Central Regulator of Metabolism.

    More Info.
    Pranela Rameshwar
    Professor
    Departmebt of Medicine-Hematology/Oncology
    Rutgers-New Jersey Medical School
    USA
    rameshwa@njms.rutgers.edu
    SSCRT

    Research Interest: Stem Cell Biology; Breast Cancer Dormancy; Neural Regulation of Hematopoiesis, the Immunology and Clinical Application of Adult Human Mesenchymal Stem Cells. 

    More Info.
    Ambrish Kumar
    Department of Pathology, Microbiology and Immunology
    University of South Carolina
    USA
    Ambrish.Kumar@uscmed.sc.edu
    SSCRT

    Research Interest: Cancer Stem Cell, Anticancer Agent, Metastasis, Cell Survival, Cell Migration, Apoptosis, Molecular and Cell Signaling, Transcription Factors, Xenograft Model, Stem Cell Based Therapy.

    More Info.
    Edgar Grinstein
    Ph.D., Senior Scientist
    Center for Child and Adolescent Health
    Heinrich Heine University, Dusseldorf
    Germany
    Edgar.Grinstein@uni-duesseldorf.de
    SSCRT

    Dr. Edgar Grinstein is a Principal Investigator at the Heinrich Heine University in Düsseldorf (Germany). He researches hematopoietic stem cells and progenitor cells, signal transduction, gene transcription regulation. He has more than 11 years of experience as Editor-In-Chief at SAGE Publications Inc. (USA) and Libertas Academica (New Zealand), and also serves as Deputy Editor-In-Chief for Baishideng Publishing Group (USA).

    Raised in a family of researchers – both parents are PhD scientists - he received his PhD summa cum laude in Molecular Biology from the Humboldt University and the Max-Delbrück Center for Molecular Medicine in Berlin. He has published a number of papers in high-ranking journals and received a highly regarded Research Award from Dr.-Günther- and Imme-Wille-Foundation. Dr. Grinstein qualified as Professor in Molecular Medicine at the University of Düsseldorf in 2008 and is a Visiting Professor at the University of Latvia (Latvia, European Union) since 2010.  

    Dr. Grinstein`s research in the field of hematopoietic stem and progenitor cells, funded by research grants from German Research Foundation (DFG) and José Carreras Leukämie-Stiftung (José Carreras Foundation), has focused on markers, signal transduction and transcriptional control. Among other important findings made, his research group provided new insights into the role of the prominent surface marker AC133/CD133 (Leukemia 2015; 29: 2208-2220), that is expressed on stem/progenitor cells in normal hematopoiesis as well as on tumor-initiating cells in certain hematological malignancies. The study analyzed the control of AC133/CD133 expression in hematopoietic stem/progenitor cells, and revealed the impact thereof on molecular network relevant to these cells.

    Research Interest: hematopoietic stem cells and progenitor cells, cancer stem cells, stem cell markers, signal transduction, cell cycle control, regulation of apoptosis, gene transcription regulation

    Grants: Principal Investigator of stem cell-related projects funded by German Research Foundation (DFG) and by José Carreras Leukämie-Stiftung (José Carreras Foundation)

    URL: https://www.wjgnet.com/2218-6204/MemberDetail/42530

    publications:

    Grinstein, E., and H.-D. Royer. 1995. Multiple octamer-binding proteins are targets for the cell cycle regulated nuclear inhibitor I-92. DNA Cell Biol. 14: 493-500.

    Grinstein, E., I. Weinert, B. Droese, M. Pagano, and H.-D. Royer. 1996. Cell cycle regulation of nuclear factor p92 DNA-binding activity by novel phase-specific inhibitors. J. Biol. Chem. 271: 9215-9222.

    Bargou, R.C., C. Wagener, K. Bommert, W. Arnold, P.T. Daniel, M.Y. Mapara, E. Grinstein, H.-D. Royer, and B. Dörken. 1996. Blocking of transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice. J. Exp. Med. 183: 1205-1213.

    Bargou, R.C., F. Emmerich, D. Krappmann, K. Bommert, M.Y. Mapara, W. Arnold, H.-D. Royer, E. Grinstein, A. Greiner, C. Scheidereit, and B. Dörken. 1997. Constitutive nuclear factor kappaB-RelA activation is required for proliferation and survival of Hodkin’s desease tumor cells. J. Clin. Invest. 12: 2961-2969.

    Janke, J., K. Schlüter, B. Jandrig, M. Theile, K. Kölble, W. Arnold, E. Grinstein, A.  Schwartz, L.E. Schwarz, P.M. Schlag, B.M. Jockusch, and S. Scherneck. 2000. Suppression of tumoriginecity in breast cancer cells by the microfilament protein profilin1. J. Exp. Med. 191: 1675-1685.

    Grinstein, E.,* F. Jundt, I. Weinert, P. Wernet, and H.-D. Royer. 2002. Sp1 as G1 cell cycle phase specific transcription factor in epithelial cells. Oncogene. 21: 1485-1492.

    Grinstein, E., P. Wernet, P.J. Snijders, F. Rösl, I. Weinert, W. Jia, R. Kraft, Ch. Schewe, M. Schwabe, S. Hauptmann, M. Dietel, Ch. Meijer, and H.-D. Royer. 2002. Nucleolin as activator of human papillomavirus type 18 oncogene transcription in cervical cancer. J. Exp. Med. 196: 1067-1078.

    Grinstein, E.,* Y. Shan, L. Karawajew, P.J. Snijders, C.J. Meijer, H.-D. Royer, and P. Wernet. 2006. Cell cycle controlled interaction of nucleolin with the retinoblastoma protein and cancerous cell transformation.  J. Biol. Chem. 281: 22223-22235.

    Grinstein, E.,* Y. Du, S. Santourlidis, J. Christ, M. Uhrberg, and P. Wernet. 2007. Nucleolin regulates gene expression in CD34 positive hematopoietic cells. J. Biol. Chem. 282: 12439-12449.

    Grinstein, E.,* and P. Wernet. 2007. Cellular signaling in normal and cancerous stem cells. Cell. Signal. 19: 2428-2433.
    This was the most read article of the Journal Cell. Signal. from July 2007 till March 2008. Source: SCIENCEDIRECT TOP 25 HOTTEST ARTICLES

    Wethkamp, N., H. Hanenberg, C. Suschek, W. Wetzel, S. Heikaus, E. Grinstein, U. Ramp, R. Engers, H. Gabbert, and C. Mahotka. 2011. DAXX-beta and DAXX-gamma: two novel splice variants of the transcriptional co-repressor DAXX. J. Biol. Chem. 19576-19588.

    Grinstein, E.,* C. Mahotka, and A. Borkhardt. 2011. Rb and nucleolin antagonize in controlling human CD34 gene expression. Cell. Signal. 23: 1358-1365.

    Bhatia, S., S. Reister, C. Mahotka, R. Meisel, A. Borkhardt, and E. Grinstein.* 2015. Control of AC133 / CD133 and impact on human hematopoietic progenitor cells through nucleolin. Leukemia. 29: 2208-2220.

    Mahotka, C., S. Bhatia, J. Kollet, and E. Grinstein.* 2018. Nucleolin promotes execution of the hematopoietic stem cell gene expression program. Leukemia. 32: 1865–1868.

    Reister, S., C. Mahotka, N. van den Höfel, and  E. Grinstein.* 2019. Nucleolin promotes Wnt signaling in human hematopoietic stem/progenitor cells. Leukemia. 33: 1052-1054.


    More Info.
    Chih-long Chang
    Director
    Department of Obstetrics and Gynecology
    Mackay Memorial Hospital
    Taiwan
    clchang@mmc.edu.tw
    SSCRT

    Research Interest: Tumor Immunology and Immunotherapy, Cancer Stem Cell Biology and Immunology, Obstetrics and Gynecology.

    More Info.
    Ming Li
    Associate Professor
    Department of Stem Cell Disorders
    Kansai Medical University
    Japan
    lg6763@yahoo.co.jp
    SSCRT

    Research Interest: Focuses on Aging-Related Diseases and Stem Cell Transplantation. 

    More Info.
    George Kolios
    Professor
    Head of the Laboratory of Pharmacology
    Democritus University of Thrace
    Greece
    gkolios@med.duth.gr
    SSCRT

    Research Interest: Clinical Pharmacology, Gastroenterology, Pharmaceutical Development, Drug Development, Colorectal Cancer, Inflammatory Bowel Disease, Ulcerative Colitis, Crohn's Disease

    More Info.
    Valarmathi Mani Thiruvanamalai
    Department of Comparative Biosciences
    University of Illinois
    USA
    valarmathi64@hotmail.com
    SSCRT

    Research Interest: Cardiac Therapy, Cardiovascular Disease, Autologous, Tissue-Engineering, Multipotent Stem Cells, Cardiovascular Structures, Regenerative Medicine.

    More Info.
    Han Wang
    Department of Cellular and Structural Biology
    University of Texas
    USA
    cherrywangh@hotmail.com
    SSCRT

    Research Interest: Embryonic Stem Cells, Pluripotency, Induced Pluripotent Cells, Differentiation, Endoderm, Beta Cell, Diabetes, Obesity, Adipose Tissue, Brown Fat, Endothelium, Oxidative Stress, Nitric Oxide, Peroxynitrite, Superoxide, Nanosensors.

    More Info.
    Milton Artur Ruiz
    VP South and Central America International Society for Cellular Therapy
    Brazil
    milruiz@yahoo.com.br
    SSCRT

    Research Interest: Hematopoietic Stem Cell Transplanting, Cell Therapy and Everything in the Field of Publication and Education.

    More Info.
    Umberto Galderisi
    Professor
    Department of Experimental Medicine
    University of Naples
    Italy
    umberto.galderisi@unina2.it
    SSCRT

    Research Interest: Genes Involved in Cell Cycle Regulation, Differentiation, Apoptosis and Senescence Such as the Retinoblastoma (RB) Family. He has Evaluated the Role of Retinoblastoma Genes in the Regulation of Cell Proliferation, Differentiation and Apoptosis in
    Cancer and Normal Stem Cells. In Detail, his Group has Analyzed the Biology of Neural Stem Cells and Mesenchymal Stem Cells. These Studies Prompted the Attention Also on Chromatin
    Remodeling Factors that Interact with RB Family Members and Play a Key Role in the Life of StemCells.

    More Info.
    Toru Hosoda
    Associate Professor
    Tokai University
    Japan
    thosoda@zeus.bwh.harvard.edu
    SSCRT

    Research Interest: Resident Cardiac Stem Cells, Myocardial Regeneration in Basic and Clinical/Translational Studies.

    More Info.
    Guojun Wu
    Associate Professor
    Department of Oncology
    Wayne State University School of Medicine
    USA
    wugu@karmanos.org
    SSCRT

    Research Interest:

    Two Major Projects are Currently Underway in the Laboratory.
    A Cell Reprogramming Technique Has Been Used to Convert Heterogeneous Malignant Breast Cancer Cells into Induced Pluripotent Stem Cells Using Sox2/Oct4/Nanog Proteins. Dr. Wu’s Laboratory is Clarifying these Induced Pluripotent Stem Cells for their Differentiation Potential and Oncogenic Properties, and Try to Develop a Novel Cell Converting Therapy for Malignant Breast Cancer Treatment.
    Metastasis, the Spread of Cancer Cells from the Primary Tumor To Distant Organs, Is The Most Dreadful Development Of Breast Cancer, As Well As Other Neoplastic Diseases. Although Metastasis Contributes To Over 90% Of Human Cancer Mortality, The Molecular Mechanism Of This Process Remains Largely Unknown. Dr. Wu’s Laboratory Is In The Process Of Identifying Molecular Signatures Involved In Breast Cancer Metastasis Using Integrative Genetic, Epigenetic And Proteomic Approach, As Well As Animal Models And Clinical Specimens. 

    More Info.
    View more
    mendeley

    Bovine whey improved the myocardial and lung damage of mother rats fed on a high fat diet

    Published On: February 28, 2020 | Pages: 001 - 008

    Author(s): Hassan IH El-Sayyad*, Hebat A el-Ghawet, Khaled SM El-Bayomi and Eman Emara
    Abstract View Full Article View
    mendeley

    The potential effects of pomegranate peel extract and bee venom in improving the diabetes induced damaging of spiral artery

    DOI Logo 10.17352/sscrt.000013

    Published On: December 27, 2019 | Pages: 007 - 011

    Author(s): El-Sayyad HIH*, El-Ghawet HA and El-Sayed AMA
    Abstract View Full Article View
    mendeley

    Evaluation of success and toxicity of autologous stem cell transplantation in patients with multiple myeloma in the geriatric age group

    DOI Logo 10.17352/sscrt.000012

    Published On: August 03, 2019 | Pages: 000 - 006

    Author(s): Mehmet Ali Uçar*, Simten Dağdaş, Funda Ceran, Mesude Falay and Gülsüm Özet
    Abstract View Full Article View
    mendeley

    Cell-Penetrating Peptides as a Tool to Deliver Biologically Active Recombinant Proteins to Generate Transgene-Free Induced Pluripotent Stem Cells

    DOI Logo 10.17352/sscrt.000011

    Published On: April 01, 2017 | Pages: 006 - 015

    Author(s): Chandrima Dey, Gloria Narayan, H Krishna Kumar, Manash P Borgohain, Nibedita Lenka and Rajkumar P Thummer*
    Abstract View Full Article View
    mendeley

    Comparison of 18F-FDG PET/CT and ceCT Results in the Assessment of RCC Recurrence

    DOI Logo 10.17352/sscrt.000010

    Published On: December 31, 2016 | Pages: 001 - 005

    Author(s): Elgin OZKAN*, Mine ARAZ, Cigdem SOYDAL and Gulseren ARAS
    Abstract View Full Article View
    mendeley

    Adipogenic and Osteogenic Markers Characterization of Human Amniotic Fluid Stem Cells

    DOI Logo 10.17352/sscrt.000009

    Published On: December 29, 2016 | Pages: 025 - 032

    Author(s): Hassan IH El-Sayyad*, Mohamed A Sobh, Soad A Khalifa, Omnia KRA El-Sayyad
    Abstract View Full Article View
    mendeley

    Adipose Derived Mesenchymal Stem Cell Differentiation into Adipogenic and Osteogenic Stem Cells

    DOI Logo 10.17352/sscrt.000008

    Published On: December 29, 2016 | Pages: 017 - 024

    Author(s): Hassan IH El Sayyad1*, Mohamed A Sobh2, Soad A Khalifa1 and Omnia KR El-Sayyad
    Abstract View Full Article View
    mendeley

    A New Catheter Technology to Deliver Vascular Stem-Cells

    DOI Logo 10.17352/sscrt.000007

    Published On: December 13, 2016 | Pages: 007 - 016

    Author(s): Brian D Plourde, John R Stark and John P Abraham*
    Abstract View Full Article View
    mendeley

    Cytokine Production by Circulating Endothelial Progenitor Cells before and after G-CSF Mobilization

    DOI Logo 10.17352/sscrt.000006

    Published On: November 29, 2016 | Pages: 001 - 006

    Author(s): Alexander Lykov*, Olga Poveschenko, Natalia Bondarenko, Alexander Poveschenko, Irina Kim, Eugenie Pokushalov, Alexander Romanov and Vladimir Konenkov
    Abstract View Full Article View
    mendeley

    Mesenchymal Stem Cell as a Vector for Gene and Cell therapy Strategies

    DOI Logo 10.17352/sscrt.000005

    Published On: December 31, 2015 | Pages: 017 - 018

    Author(s): Abdolreza Esmaeilzadeh 1* and Alieh Farshbaf
    Abstract View Full Article View

     

    Clients' voices

    Readmore

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on SSCRT